Table: Haba Laboratories Inc -Q1 group results
Aug 12 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2020 Jun 30, 2019 Mar 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 3.22 4.50 16.77
(-28.4 pct) (+3.4 pct) (-8.7 pct)
Operating loss 309 mln 673 mln 1.52
(+52.5 pct) (-23.9 pct)
Recurring loss 308 mln 673 mln 1.50
(+51.0 pct) (-24.1 pct)
Net loss 195 mln 428 mln 1.02
(+49.4 pct) (-22.3 pct)
EPS loss 51.61 yen 109.06 yen 269.73 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T